Skip to main content

Table 3 The changes in ALAT, ASAT, ALP and Bilirubin levels after oral therapy with SPW1

From: Glycoside rich fraction from Spondias pinnata bark ameliorate iron overload induced oxidative stress and hepatic damage in Swiss albino mice

Treatment

ALAT

ASAT

ALP

Bilirubin

Unit/L

% change

Unit/L

% change

Unit/L

% change

mg/dl

% change

B

14.42 ± 1.91

 

62.46 ± 6.32

 

84.62 ± 3.48

 

1.58 ± 0.10

 

C

64.60 ± 0.73 X3

347.88

234.91 ± 8.30 X3

276.13

252.63 ± 4.92 X3

198.56

3.15 ± 0.18 X3

99.67

S50

36.19 ± 1.16 X3Y3

150.91

170.49 ± 12.54 X3Y3

172.97

181.71 ± 6.18 X3Y3

114.74

2.42 ± 0.25 X2Y2

53.43

S100

27.47 ± 1.55 X3Y3

90.45

137.29 ± 17.82 X3Y3

119.82

149.48 ± 7.02 X3Y3

76.66

2.18 ± 0.12 X3Y3

38.41

S200

20.11 ± 0.16 X2Y3

39.41

97.62 ± 8.16 X3Y3

56.31

125.08 ± 5.93 X3Y3

47.81

1.99 ± 0.13 X3Y3

26.22

D

19.85 ± 0.79 X3Y3

37.59

88.06 ± 10.37 X2Y3

40.99

114.97 ± 6.13 X3Y3

35.87

1.72 ± 0.14 X1Y3

8.92

  1. Mouse groups (B; C; S50, S100, S200, D) were treated as described in ‘Experimental design’ section. Values are mean ± SD (n = 6). X1: p < 0.05, X2: p < 0.01 and X3: p < 0.001 significant difference from B group. Y1: p < 0.05, Y2: p < 0.01 and Y3: p < 0.001 significant difference from C group